A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)

NCT07063238 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: MK-8527
DRUG: Moxifloxacin
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC